Skip to main content
TipRanks
Go Ultimate75% OFF

Hemab Therapeutics Holdings, Inc. (COAG) Hedge Fund Trading Activity

16 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 0 Shares Last Quarter

Hedge Fund Holdings in COAG

8.40M$24.509.00M$32.139.60M$39.7510.20M$47.3810.80M$55.00Jul '26$39.06Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
BlackRock, Inc. hedge funds manager,  ,Rank 334BlackRock, Inc. Added392.91%$43,146,363<0.01%
Peter Kolchinsky hedge funds manager, RA Capital Management,Rank 27Peter KolchinskyRA Capital ManagementNot Changed0.00%$240,818,0572.09%
James E. Flynn hedge funds manager, Deerfield Management Company, LP,Rank 31James E. FlynnDeerfield Management Company, LPNot Changed0.00%$8,481,0000.09%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 459Michael RockefellerWoodline Partners LPNot Changed0.00%$4,627,2340.01%
Steve Weber hedge funds manager, Driehaus Capital Management LLC,Rank 51Steve WeberDriehaus Capital Management LLCReduced-1.07%$21,839,8390.13%
George Soros hedge funds manager, Soros Fund Mangment LLC,Rank 278George SorosSoros Fund Mangment LLCSold Out-100.00%$00.00%

FAQ

Which hedge funds hold Hemab Therapeutics Holdings, Inc.?
The hedge funds that hold the most shares in Hemab Therapeutics Holdings, Inc. are BlackRock, Inc., Peter Kolchinsky and James E. Flynn.
Are hedge funds buying or selling COAG?
In the last quarter hedge funds have Increased their holdings in Hemab Therapeutics Holdings, Inc. by 0 shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Hemab Therapeutics Holdings, Inc. stock?
Warren Buffet currently does not own shares in Hemab Therapeutics Holdings, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here